TGINSIGHT SIMILAR POSTS
Изворен канал @pythonotes · Post #48 · 8 мар.
Всё начиналось с библиотеки six, что означает цифру 6 и является результатом умножения 2*3 (напомню что six это библиотека для написания кода одновременно совместимого для Python 2 и 3). Но как обычно всегда найдется тот, кому не всё понравится и он напишет свой вариант) В итоге получаем небольшой ряд "числовых" библиотек примерно для одного и того же https://pypi.org/project/six/ https://pypi.org/project/eight/ https://pypi.org/project/nine/ Выглядит забавно. Я решил проверить, есть ли другие библиотеки с числом в названии, хотя бы до 20. И вот что нашлось: https://pypi.org/project/one/ https://pypi.org/project/two/ https://pypi.org/project/three/ four - свободно https://pypi.org/project/five/ https://pypi.org/project/six/ https://pypi.org/project/seven/ https://pypi.org/project/eight/ https://pypi.org/project/nine/ ten - свободно https://pypi.org/project/eleven/ https://pypi.org/project/twelve/ thirteen - свободно fourteen - свободно fifteen - свободно https://pypi.org/project/sixteen/ seventeen - свободно nineteen - свободно twenty - свободно Назначения у этих проектов, конечно, разные. Есть и заброшенные и популярные. Но места еще есть 😊 Занимаем пока свободно! PS. Всех уделал Em Fresh со своей линейкой Python-альбомов😁 (жмакнуть show more) PPS. Всех читательниц моего канала поздравляю с праздником 🌼🥳💐 #offtop#libs#2to3
Пребарај: #biotechnology
@venturevillagewall · Post #3500 · 19.12.2024 г., 13:59
Xcell Biosciences Secures $1.4M Xcell Biosciences has raised $1.40 million for advancing its cell therapy manufacturing. The funding round took place on December 17, 2024. Learn more at Xcell Biosciences #XcellBiosciences#Funding#CellTherapy#SanFrancisco#Biotechnology#HealthTech
@venturevillagewall · Post #3574 · 20.12.2024 г., 09:33
Tessera Therapeutics Secures $50M Tessera Therapeutics has raised $50 million in funding on December 18, 2024. The early-stage life sciences company is at the forefront of Gene Writing™, a cutting-edge biotechnology aimed at transforming medicine and scientific research. More details available on their official website: Tessera Therapeutics #TesseraTherapeutics#Funding#LifeSciences#Biotechnology#GeneWriting#Healthcare#MedicalResearch
@venturevillagewall · Post #3627 · 21.12.2024 г., 10:22
First Oral Diabetes Therapy Funded TIXiMED has raised $2.65 million to develop TXNIP inhibiting medication, targeting Type 1 and Type 2 Diabetes with an innovative oral therapeutic. Learn more about their project here. #TIXiMED#Diabetes#Funding#Healthcare#TXNIP#Therapeutics#Type1Diabetes#Type2Diabetes#Biotechnology
@venturevillagewall · Post #3582 · 20.12.2024 г., 09:34
$140M Funding for Ottimo Pharma Ottimo Pharma announces a funding round of $140 million set for December 19, 2024. The company focuses on developing bi-functional medicines aimed at improving the lives of individuals living with cancer. Learn more #Funding#OttimoPharma#Cancer#BiFunctionalMedicines#Healthcare#Pharmaceuticals#LifeSciences#Investments#MedicalResearch#Oncology#HealthTech#Biotechnology
@venturevillagewall · Post #3557 · 20.12.2024 г., 09:32
Spine BioPharma Raises $13.51M Spine BioPharma has successfully closed a funding round totaling $13.51 million, announced on December 18, 2024. For more details, visit their official site: Spine BioPharma. #SpineBioPharma#Funding#BioPharma#Investment#Healthcare#LifeSciences#VentureCapital#Startup#ClinicalTrials#MedicinalResearch#Pharma#Innovations#Tech#Biotechnology#Market#Earnings#Growth#Investors#Equity
@venturevillagewall · Post #3629 · 21.12.2024 г., 10:22
$4.07M Funding for PeptiSystems PeptiSystems secured $4.07M in funding on December 20, 2024. The company develops advanced instruments for solid-phase synthesis in peptide and oligonucleotide therapeutics, catering to both GMP and non-GMP manufacturing. Discover more: PeptiSystems #Funding#PeptiSystems#Therapeutics#Peptides#Oligonucleotides#GMP#Manufacturing#Synthesis#Biotechnology#Pharmaceuticals#MedicalDevices#FlowthroughColumnTechnology#ProcessDevelopment#LifeSciences